Video Experimental Relacionado
Updated: Jul 13, 2026
05:51
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Identificación molecular del gen responsable de la diabetes nefrogénica insipida congénita
W Rosenthal1, A Seibold, A Antaramian
1Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
Nature
|September 17, 1992
Resumen
La diabetes nefrogénica congénita insipida (CNDI) es causada por mutaciones en el gen del receptor V2. Los investigadores identificaron una deleción y un cambio de codón en los genes del receptor V2 de los machos afectados, lo que explica la falta de respuesta renal a la hormona antidiurética.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Genética La genética.
- Nefrología Nefrología.
Sus antecedentes:
- La hormona antidiurética (arginina vasopresina) regula la reabsorción de agua a través de los receptores V2 en los túbulos recolectores renales.
- La diabetes nefrogénica congénita insípida (CNDI) es un trastorno ligado al X que se caracteriza por la resistencia renal a la arginina vasopresina.
- La activación del receptor V2 desencadena vías de señalización que aumentan la permeabilidad del agua en el conducto recolector.
Objetivo del estudio:
- Investigar la base genética de la diabetes nefrogénica insipida congénita (DINC) en las familias afectadas.
- Para identificar mutaciones en el gen del receptor V2 responsable del CNDI.
- Para correlacionar mutaciones genéticas específicas del receptor V2 con el fenotipo de la enfermedad.
Principales métodos:
- Análisis genético del gen receptor V2 en varones afectados y sus familias.
- Secuenciación de ADN para identificar mutaciones en el gen del receptor V2.
- Análisis de las deleciones de genes, cambios de marco y cambios de codón.
Principales resultados:
- Se identificó una deleción que causa un cambio de marco y terminación prematura en el gen del receptor V2 en un paciente del CNDI.
- Se encontró una mutación diferente, un cambio de codón en el tercer dominio transmembrana, en otro paciente del CNDI.
- Los varones afectados llevaban alelos mutantes del receptor V2, mientras que los hermanos no afectados tenían alelos normales.
Conclusiones:
- Las mutaciones en el gen del receptor V2 son la causa de la diabetes nefrogénica insipida congénita (DINC).
- Las mutaciones específicas, incluidas las deleciones y los cambios de codón, interrumpen la función del receptor V2, lo que lleva a una disminución de la reabsorción de agua.
- El análisis genético del gen receptor V2 es crucial para el diagnóstico de CNDI.
Videos de Conceptos Relacionados
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:43Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...